Danaher Co. (NYSE:DHR) Shares Sold by Lee Financial Co

Lee Financial Co reduced its position in Danaher Co. (NYSE:DHR) by 4.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,555 shares of the conglomerate’s stock after selling 64 shares during the quarter. Lee Financial Co’s holdings in Danaher were worth $357,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the company. AMF Tjanstepension AB acquired a new position in Danaher during the 3rd quarter worth approximately $5,923,000. Creative Planning grew its holdings in Danaher by 3.1% during the third quarter. Creative Planning now owns 126,340 shares of the conglomerate’s stock worth $35,125,000 after acquiring an additional 3,749 shares during the period. Good Life Advisors LLC acquired a new stake in Danaher in the third quarter valued at $217,000. Ellsworth Advisors LLC purchased a new stake in shares of Danaher during the 3rd quarter worth $223,000. Finally, Onyx Bridge Wealth Group LLC acquired a new position in shares of Danaher during the 3rd quarter worth $207,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on DHR. JPMorgan Chase & Co. decreased their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. UBS Group decreased their price target on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a research note on Thursday, October 31st. Stifel Nicolaus boosted their target price on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Finally, Robert W. Baird dropped their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $278.00.

Danaher Trading Up 1.5 %

Shares of Danaher stock opened at $206.66 on Friday. The firm has a market cap of $149.26 billion, a PE ratio of 39.14, a P/E/G ratio of 2.68 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70. The business’s fifty day moving average is $229.53 and its two-hundred day moving average is $249.51.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the business posted $2.09 EPS. Analysts anticipate that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.52%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio is currently 20.45%.

Insider Buying and Selling at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 11.10% of the stock is owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.